Results 241 to 250 of about 197,154 (267)
Some of the next articles are maybe not open access.
Immune Checkpoint Inhibitors in Cholangiocarcinoma
Immunotherapy, 2023Cholangiocarcinoma is an epithelial malignancy originating in the biliary tracts and frequently recurs even with surgical resection. Unresectable disease has a 5-year overall survival of less than 10%. Given this poor prognosis, additional therapies are urgently needed. Chemotherapy has been the mainstay of treatment for many years.
openaire +2 more sources
Immune Checkpoint Inhibitors May Be Safe for Patients With Preexisting Autoimmune Disease
Ca-A Cancer Journal for Clinicians, 2020Mike Fillon
exaly
A Review of Cancer Immunotherapy Toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly
Checkpoint inhibitors in the emergency department
Emergency Medicine Australasia, 2019Caroline AE Bachmeier, Adam Morton
openaire +5 more sources

